Information Provided By:
Fly News Breaks for February 19, 2020
BBIO, QTWO, IHRT, WAFD, PRVL
Feb 19, 2020 | 10:25 EDT
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Prevail Therapeutics (PRVL) initiated with an Outperform at Oppenheimer. 2. Washington Federal (WAFD) initiated with an Equal Weight at Stephens. 3. iHeartMedia (IHRT) initiated with a Buy at Guggenheim. 4. Q2 Holdings (QTWO) initiated with a Neutral at Baird. 5. BridgeBio (BBIO) initiated with a Buy at Mizuho. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
News For PRVL;WAFD;IHRT;QTWO;BBIO From the Last 2 Days
QTWO
QTWO
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.